SCHEMBL2012684

SCHEMBL2012684

COc1nccc(C(=O)N(C)C(CCNC(=O)c2nc3ccccc3n2C)Cc2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.42
HCRTR2 O43614 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.37
TSHR P16473 1/20 0.37
PDE10A Q9Y233 1/20 0.35
RECQL P46063 2/20 0.35
ALDH1A1 P00352 1/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
GAA P10253 1/20 0.35
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
ASAH1 Q13510 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2013196 0.90 HCRTR1 (0.42) HCRTR1HCRTR2SMN1; SMN2TSHRPDE10A
SCHEMBL13138972 0.84 HCRTR1 (0.50) HCRTR1HCRTR2SMN1; SMN2TSHRPDE10A
SCHEMBL13139051 0.84 HCRTR1 (0.47) HCRTR1HCRTR2SMN1; SMN2PDE10AALDH1A1
SCHEMBL13139031 0.83 HCRTR1 (0.57) HCRTR1HCRTR2SMN1; SMN2RECQLALDH1A1
SCHEMBL2052690 0.83 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2016348 0.83 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2014285 0.82 EPHX2 (0.45) HCRTR1HCRTR2SMN1; SMN2
SCHEMBL13139038 0.82 HCRTR1 (0.48) HCRTR1HCRTR2SMN1; SMN2TSHRALDH1A1
SCHEMBL2051291 0.81 HCRTR1 (0.43) HCRTR1HCRTR2SMN1; SMN2ALDH1A1NPC1
SCHEMBL2014592 0.81 HCRTR1 (0.43) HCRTR1HCRTR2SMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed